|
|
| | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, dianhydride with 9-octadecenoic acid, (Z,Z)- (9CI) Basic information |
| Product Name: | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, dianhydride with 9-octadecenoic acid, (Z,Z)- (9CI) | | Synonyms: | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, dianhydride with 9-octadecenoic acid, (Z,Z)- (9CI);Dioleoylmethotrexate | | CAS: | 141456-07-7 | | MF: | C56H86N8O7 | | MW: | 983.35 | | EINECS: | | | Product Categories: | | | Mol File: | 141456-07-7.mol | ![L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, dianhydride with 9-octadecenoic acid, (Z,Z)- (9CI) Structure](CAS/20211123/GIF/141456-07-7.gif) |
| | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, dianhydride with 9-octadecenoic acid, (Z,Z)- (9CI) Chemical Properties |
| density | 1.105±0.06 g/cm3(Predicted) | | pka | 13.09±0.46(Predicted) |
| | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, dianhydride with 9-octadecenoic acid, (Z,Z)- (9CI) Usage And Synthesis |
| Description | Dioleoylmethotrexate is an antineoplastic drug. |
| | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, dianhydride with 9-octadecenoic acid, (Z,Z)- (9CI) Preparation Products And Raw materials |
|